Study of RC220 with Doxorubicin for Advanced Solid Tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called RC220 combined with the chemotherapy doxorubicin for people with advanced solid tumors that have not responded to prior treatments. The goal is to find a safe dose and see how the body handles the combination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old (19 and older if in Korea).
- You need to have a solid tumor that is advanced or has spread and cannot be removed by surgery, and for which doxorubicin is a treatment option.
- You should be able to perform daily activities with little or no help (ECOG score 0 or 1).
- Your blood counts, liver function, and kidney function must be within certain limits as determined by tests.
- You must agree to use effective birth control during and for a period after the study.
- You cannot have had cancer treatment, major surgery, or certain infections within specific timeframes before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called RC278 for people with solid tumors that have not spread to the brain. It aims to see if the drug is safe and effective, and may be an option for those who are otherwise fairly healthy.
This study tests a new drug called RC288 to treat solid tumors (cancers that form lumps). Researchers want to see if it's safe and how well it works for people whose cancer hasn't responded to other treatments or has returned.
This trial tests a new drug called BM230 for people with advanced solid tumors that have HER2 protein or gene changes. It aims to see if the drug is safe and effective for those who have run out of standard treatment options.
This trial tests an experimental drug called HRS-3802 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and how the body processes it.
This trial tests a new drug called RC148, both alone and combined with other treatments, for people with advanced solid tumors that haven't responded to standard therapy. It includes several groups for specific cancers (like non-small cell lung, cervical, stomach, and ovarian cancer) to see if RC148 can shrink tumors or slow their growth.
This trial tests a new combination treatment (HC010) for people with advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
Hear when a new Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.